Table 2 The demographic data and characters of PE in different types of cancers
From: The incidence and clinical characteristics of pulmonary embolism in oncologic patients
Ca breast (8) | Ca colon (5) | Ca prostate (2) | Ca pancreas (2) | Ca gall bladder (2) | Ca larynx (1) | Ca lung (1) | Ca uterus (1) | Seminoma and germ cell tumor (2) | |
|---|---|---|---|---|---|---|---|---|---|
Age (M ± SD) | 52 ± 11 | 60.4 ± 13 | 84 ± 15 | 56.5 ± 11 | 52.4 ± 9 | 37 | 61 | 55 | 32.5 ± 9 |
Sex: | |||||||||
Male | – | 2 (40%) | 2 (100%) | 1 (50%) | 1 (50%) | – | 1 (100%) | – | 2 (100%) |
Female | 8 (100%) | 3 (60%) | – | 1 (50%) | 1 (50%) | 1 (100%) | – | 1 (100%) | –- |
Smoking history: | |||||||||
Non | 5 (62.5%) | 2 (40%) | ––- | ––- | 1 (50%) | –– | –– | 1 (100%) | 2 (100%) |
Mild | 3 (37.5%) | 2 (40%) | 2 (100%) | 2 (100%) | 1 (50%) | 1 (100%) | –- | –- | –- |
Moderate | –- | 1 (20%) | –– | –- | –- | –- | 1 (100%) | –– | ––- |
Heavy | –- | –– | ––- | –– | –- | –– | ––- | ––- | ––– |
Stage of Ca: | |||||||||
II | 2 (25%) | 1 (20%) | – | – | – | – | – | – | 1 (50%) |
III | 2 (25%) | – | – | – | – | – | – | – | – |
VI | 4 (50%) | 4 (80%) | 2 (100%) | 2 (100%) | 2 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (50%) |
Treat of Ca: | |||||||||
Chemo | 5 (62.5%) | 2 (40%) | – | – | 1 (50%) | – | 1 (100%) | 1 (100%) | 2 (100%) |
Radio | – | – | – | – | – | – | – | – | – |
Hormonal | 2 (25%) | – | 2 (100%) | – | – | – | – | – | – |
No | 1 (12.5%) | 3 (60%) | – | 2 (100%) | 1 (50%) | 1 (100%) | – | – | – |
Time of PE: | |||||||||
First 6 months | - | ||||||||
Incidental | 1 (12.5%) | 1 (20%) | – | 2 (100%) | 1 (50%) | - | 1 (100%) | 1 (100%) | – |
On diagnosis | – | 2 (40%) | – | 2 (100%) | – | – | 1 (100%) | 1 (100%) | – |
On chemo | 5 (62.5%) | 2 (40%) | – | – | 1 (50%) | – | – | – | 2 (100%) |
On hormonal | 2 (25%) | – | 2 (100%) | – | – | – | –- | – | – |
Follow up (1–2 years | 1 (12.5%) | – | 2 (100%) | – | – | 1 (100%) | – | – | – |
Degree of PE: | |||||||||
Massive | 2 (25%) | – | – | – | – | – | – | – | 1 (50%) |
Sub-massive | – | 2 (40%) | – | – | –- | 1 (100%) | – | – | – |
Low risk | 6 (75%) | 3 (60%) | 2 (100%) | 2 (100%) | 2 (100%) | – | 1 (100%) | 1 (100%) | 1 (50%) |
Treat of PE | |||||||||
Thrombolytic | 1 (12.5%) | – | – | – | – | – | – | – | – |
IV heparin | 2 (25%) | – | – | – | – | – | – | – | 1 (50%) |
LMWH | 7 (87.5%) | 5 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | 1 (100%) | 1 (100%) | 1 (100%) | 1 (50%) |
IVC filter | – | 1 (20%) | – | – | – | 1 (100%) | – | – | –- |